{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:58Z","timestamp":1792784278100,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Ministry of Science, Technological Development and Innovations of the Republic of Serbia","award":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"],"award-info":[{"award-number":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"]}],"id":[{"id":"https:\/\/ror.org\/01znas443","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Ministry of Science, Technological Development and Innovations of the Republic of Serbia","award":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"],"award-info":[{"award-number":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"]}],"id":[{"id":"https:\/\/ror.org\/01znas443","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Ministry of Science, Technological Development and Innovations of the Republic of Serbia","award":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"],"award-info":[{"award-number":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"]}],"id":[{"id":"https:\/\/ror.org\/01znas443","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Ministry of Science, Technological Development and Innovations of the Republic of Serbia","award":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"],"award-info":[{"award-number":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"]}],"id":[{"id":"https:\/\/ror.org\/01znas443","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Ministry of Science, Technological Development and Innovations of the Republic of Serbia","award":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"],"award-info":[{"award-number":["Agreement No. 451-03-65\/2024-01 and Agreement No. 451-03-66\/2024-03"]}],"id":[{"id":"https:\/\/ror.org\/01znas443","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12035-025-04958-7","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:58:15Z","timestamp":1745571495000},"page":"11286-11296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Causal Variants in CHRNA1 and CHRNB1 Genes for Anti-acetylcholine Receptor Antibody Positive Myasthenia Gravis: Evidence from Bayesian Fine-Mapping and Genetic Association Study"],"prefix":"10.1007","volume":"62","author":[{"given":"Nemanja","family":"Garai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stojan","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Djordjevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan","family":"Pesovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Brkusanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Brajuskovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Lavrnic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodan","family":"Apostolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir M.","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusanka","family":"Savic-Pavicevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"4958_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","volume":"11","author":"K Lazaridis","year":"2020","unstructured":"Lazaridis K, Tzartos SJ (2020) Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics. Front Immunol 11:212","journal-title":"Front Immunol"},{"issue":"10","key":"4958_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. The Lancet Neurology 14(10):1023\u20131036","journal-title":"The Lancet Neurology"},{"issue":"1","key":"4958_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren J (2019) Myasthenia gravis Nature reviews Disease primers 5(1):30","journal-title":"Myasthenia gravis Nature reviews Disease primers"},{"key":"4958_CR4","doi-asserted-by":"crossref","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. Journal of clinical medicine. 2021;10(11).","DOI":"10.3390\/jcm10112235"},{"key":"4958_CR5","doi-asserted-by":"crossref","unstructured":"Chia R, Saez-Atienzar S, Murphy N, Chio A, Blauwendraat C, International Myasthenia Gravis Genomics C, et al. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study. Proceedings of the National Academy of Sciences of the United States of America. 2022;119(5).","DOI":"10.1073\/pnas.2206754119"},{"issue":"6","key":"4958_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ana.23691","volume":"72","author":"PK Gregersen","year":"2012","unstructured":"Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, McKee D et al (2012) Risk for myasthenia gravis maps to a (151) Pro\u2013>Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol 72(6):927\u2013935","journal-title":"Ann Neurol"},{"issue":"4","key":"4958_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","volume":"72","author":"AE Renton","year":"2015","unstructured":"Renton AE, Pliner HA, Provenzano C, Evoli A, Ricciardi R, Nalls MA et al (2015) A genome-wide association study of myasthenia gravis. JAMA Neurol 72(4):396\u2013404","journal-title":"JAMA Neurol"},{"issue":"1","key":"4958_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2119\/molmed.2015.00232","volume":"21","author":"MF Seldin","year":"2016","unstructured":"Seldin MF, Alkhairy OK, Lee AT, Lamb JA, Sussman J, Pirskanen-Matell R et al (2016) Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A and identification of ZBTB10 and three distinct HLA associations. Mol Med 21(1):769\u2013781","journal-title":"Mol Med"},{"issue":"1","key":"4958_CR9","doi-asserted-by":"publisher","first-page":"9839","DOI":"10.1038\/s41467-024-53595-6","volume":"15","author":"A Braun","year":"2024","unstructured":"Braun A, Shekhar S, Levey DF, Straub P, Kraft J, Panagiotaropoulou GM et al (2024) Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction. Nat Commun 15(1):9839","journal-title":"Nat Commun"},{"issue":"36","key":"4958_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207273119","volume":"119","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Chen X, Wang C, Cheng L (2022) Novel genes\/loci validate the small effect size of ERBB2 in patients with myasthenia gravis. Proc Natl Acad Sci USA 119(36):e2207273119","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4958_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajhg.2011.11.029","volume":"90","author":"PM Visscher","year":"2012","unstructured":"Visscher PM, Brown MA, McCarthy MI, Yang J (2012) Five years of GWAS discovery. Am J Hum Genet 90(1):7\u201324","journal-title":"Am J Hum Genet"},{"issue":"8","key":"4958_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","volume":"20","author":"V Tam","year":"2019","unstructured":"Tam V, Patel N, Turcotte M, Bosse Y, Pare G, Meyre D (2019) Benefits and limitations of genome-wide association studies. Nat Rev Genet 20(8):467\u2013484","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4958_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00281-021-00902-8","volume":"44","author":"QS Wang","year":"2022","unstructured":"Wang QS, Huang H (2022) Methods for statistical fine-mapping and their applications to auto-immune diseases. Seminars in immunopathology 44(1):101\u2013113","journal-title":"Seminars in immunopathology"},{"key":"4958_CR14","doi-asserted-by":"crossref","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafo MR, et al. Mendelian randomization. Nature reviews Methods primers. 2022;2.","DOI":"10.1038\/s43586-021-00092-5"},{"issue":"8","key":"4958_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41576-018-0016-z","volume":"19","author":"DJ Schaid","year":"2018","unstructured":"Schaid DJ, Chen W, Larson NB (2018) From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat Rev Genet 19(8):491\u2013504","journal-title":"Nat Rev Genet"},{"key":"4958_CR16","doi-asserted-by":"crossref","unstructured":"Gerber Z, Fisun M, Aschard H, Djebali S. PaintorPipe: a pipeline for genetic variant fine-mapping using functional annotations. Bioinformatics advances. 2024;4(1):vbad188.","DOI":"10.1093\/bioadv\/vbad188"},{"issue":"10","key":"4958_CR17","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/bioinformatics\/btw018","volume":"32","author":"C Benner","year":"2016","unstructured":"Benner C, Spencer CC, Havulinna AS, Salomaa V, Ripatti S, Pirinen M (2016) FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32(10):1493\u20131501","journal-title":"Bioinformatics"},{"issue":"10","key":"4958_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004722","volume":"10","author":"G Kichaev","year":"2014","unstructured":"Kichaev G, Yang WY, Lindstrom S, Hormozdiari F, Eskin E, Price AL et al (2014) Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet 10(10):e1004722","journal-title":"PLoS Genet"},{"issue":"9","key":"4958_CR19","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gr.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M et al (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 22(9):1790\u20131797","journal-title":"Genome Res"},{"issue":"5","key":"4958_CR20","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41588-023-01365-3","volume":"55","author":"S Dong","year":"2023","unstructured":"Dong S, Zhao N, Spragins E, Kagda MS, Li M, Assis P et al (2023) Annotating and prioritizing human non-coding variants with RegulomeDB vol 2. Nat Genet 55(5):724\u2013726","journal-title":"Nat Genet"},{"issue":"1","key":"4958_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A et al (2016) The ensembl variant effect predictor. Genome Biol 17(1):122","journal-title":"Genome Biol"},{"issue":"D1","key":"4958_CR22","doi-asserted-by":"publisher","first-page":"D933","DOI":"10.1093\/nar\/gkac958","volume":"51","author":"FJ Martin","year":"2023","unstructured":"Martin FJ, Amode MR, Aneja A, Austine-Orimoloye O, Azov AG, Barnes I et al (2023) Ensembl 2023. Nucleic Acids Res 51(D1):D933\u2013D941","journal-title":"Nucleic Acids Res"},{"key":"4958_CR23","unstructured":"Adobe. Adobe Illustrator (Version 27.0). Adobe Inc; 2023."},{"key":"4958_CR24","doi-asserted-by":"crossref","unstructured":"Jaretzki A, 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. The Annals of thoracic surgery. 2000;70(1):327\u201334.","DOI":"10.1016\/S0003-4975(00)01595-2"},{"key":"4958_CR25","doi-asserted-by":"crossref","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8(5):475\u201390","DOI":"10.1016\/S1474-4422(09)70063-8"},{"key":"4958_CR26","unstructured":"Team RC (2023) R: a language and environment for statistical computing. R Foundation for Statistical Computing. https:\/\/www.r-project.org\/. Accessed 15 Oct 2024"},{"issue":"3","key":"4958_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559\u2013575","journal-title":"Am J Hum Genet"},{"key":"4958_CR28","unstructured":"Jacobson CMaS. genpwr: power calculations under genetic model misspecification. 2021."},{"issue":"11","key":"4958_CR29","doi-asserted-by":"publisher","first-page":"9539","DOI":"10.1007\/s12035-024-04183-8","volume":"61","author":"I Djordjevic","year":"2024","unstructured":"Djordjevic I, Garai N, Peric S, Karanovic J, Pesovic J, Brkusanin M et al (2024) Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and early-onset anti-acetylcholine receptor-positive myasthenia gravis in serbian patients. Mol Neurobiol 61(11):9539\u20139547","journal-title":"Mol Neurobiol"},{"key":"4958_CR30","doi-asserted-by":"crossref","unstructured":"Harrison PW, Amode MR, Austine-Orimoloye O, Azov AG, Barba M, Barnes I, et al. Ensembl 2024. 2024;52(D1):D891-d9.","DOI":"10.1093\/nar\/gkad1049"},{"issue":"4","key":"4958_CR31","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1084\/jem.147.4.973","volume":"147","author":"VA Lennon","year":"1978","unstructured":"Lennon VA, Seybold ME, Lindstrom JM, Cochrane C, Ulevitch R (1978) Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med 147(4):973\u2013983","journal-title":"J Exp Med"},{"issue":"20","key":"4958_CR32","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","volume":"298","author":"DB Drachman","year":"1978","unstructured":"Drachman DB, Angus CW, Adams RN, Michelson JD, Hoffman GJ (1978) Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 298(20):1116\u20131122","journal-title":"N Engl J Med"},{"issue":"13","key":"4958_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1056\/NEJM198209233071301","volume":"307","author":"DB Drachman","year":"1982","unstructured":"Drachman DB, Adams RN, Josifek LF, Self SG (1982) Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 307(13):769\u2013775","journal-title":"N Engl J Med"},{"issue":"1","key":"4958_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/ene.15565","volume":"30","author":"A Meisel","year":"2023","unstructured":"Meisel A, Baggi F, Behin A, Evoli A, Kostera-Pruszczyk A, Mantegazza R et al (2023) Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal. Eur J Neurol 30(1):266\u2013282","journal-title":"Eur J Neurol"},{"key":"4958_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","volume":"52","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90\u2013100","journal-title":"J Autoimmun"},{"issue":"7156","key":"4958_CR36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nature06066","volume":"448","author":"M Giraud","year":"2007","unstructured":"Giraud M, Taubert R, Vandiedonck C, Ke X, Levi-Strauss M, Pagani F et al (2007) An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature 448(7156):934\u2013937","journal-title":"Nature"},{"issue":"8","key":"4958_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/jmedgenet-2021-107953","volume":"59","author":"A Topaloudi","year":"2022","unstructured":"Topaloudi A, Zagoriti Z, Flint AC, Martinez MB, Yang Z, Tsetsos F et al (2022) Myasthenia gravis genome-wide association study implicates AGRN as a risk locus. J Med Genet 59(8):801\u2013809","journal-title":"J Med Genet"},{"issue":"4","key":"4958_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1086\/429096","volume":"76","author":"LA Criswell","year":"2005","unstructured":"Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M et al (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76(4):561\u2013571","journal-title":"Am J Hum Genet"},{"issue":"1","key":"4958_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13023-019-1025-5","volume":"14","author":"J Finsterer","year":"2019","unstructured":"Finsterer J (2019) Congenital myasthenic syndromes. Orphanet J Rare Dis 14(1):57","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"4958_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/ajmg.a.62011","volume":"185","author":"AS Freed","year":"2021","unstructured":"Freed AS, Schwarz AC, Brei BK, Clowes Candadai SV, Thies J, Mah JK et al (2021) CHRNB1-associated congenital myasthenia syndrome: expanding the clinical spectrum. Am J Med Genet A 185(3):827\u2013835","journal-title":"Am J Med Genet A"},{"issue":"4","key":"4958_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ajhg.2018.08.017","volume":"103","author":"MK Freund","year":"2018","unstructured":"Freund MK, Burch KS, Shi H, Mancuso N, Kichaev G, Garske KM et al (2018) Phenotype-specific enrichment of Mendelian disorder genes near GWAS regions across 62 complex traits. Am J Hum Genet 103(4):535\u2013552","journal-title":"Am J Hum Genet"},{"issue":"9","key":"4958_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Str\u00f6bel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12(9):875\u2013884","journal-title":"Autoimmun Rev"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04958-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:06:27Z","timestamp":1757160387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04958-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4958"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04958-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Board of the University Clinical Center of Serbia (No.187\/14). This study was performed in line with the principles of the Declaration of Helsinki. After a detailed discussion on the objectives and requirements of the study, written informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}